ARCHIVES

Drug Development: FDA Grants Breakthrough Therapy Designation to CTL019 In ALL

This article is from The Cancer Letter archive.

Vol. 40 No. 28 | July 11, 2014

Download PDF Visit The Full Archive

Related Articles

Group Lobby To Add $200 Mil. To Cancer Budget

April 26, 1991

Cancel Panel Activity Ceases Due To Hammer’s Death; Oxy Chairman Promoted Funding Of Research

January 4, 1991

ACS Asks Congress For $1.32 Billion NCI ’87 Budget

April 4, 1986

Gori Tells McGovern Committee Diet Causes Major Share Of Cancer

August 6, 1976

Wichita CCOP Stopped Accrual For Two Months, PI Says.

May 12, 2006

In Brief: CTEP Files IND For Antineoplaston, Mayo, MSK, Plan Trials; Researcher Escapes Bosnia

August 6, 1993